XML 85 R71.htm IDEA: XBRL DOCUMENT v3.25.2
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Net revenue $ 27,377 $ 28,090 $ 55,009 $ 54,052
Direct operating costs 14,480 15,242 29,944 30,419
Selling and marketing 1,118 1,664 2,249 3,434
General and administrative 4,358 4,028 8,690 7,749
Research and development 1,020 1,055 2,255 1,968
Depreciation and amortization 3,382 3,714 6,719 7,644
Restructuring costs 23 116 137 438
Total operating expenses 24,381 25,819 49,994 51,652
OPERATING INCOME 2,996 2,271 5,015 2,400
Unallocated corporate expenses (1,446) (1,530) (3,024) (2,236)
Net interest expense (17) (264) (33) (602)
Other expenses (35) (294) (49) (287)
Income before income taxes 2,944 1,713 4,933 1,511
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Net revenue 27,377 28,090 55,009 54,052
Direct operating costs 14,480 15,242 29,944 30,419
Selling and marketing 1,118 1,664 2,249 3,434
General and administrative 2,912 2,498 5,666 5,513
Research and development 1,020 1,055 2,255 1,968
Depreciation and amortization 3,382 3,714 6,719 7,644
Restructuring costs 23 116 137 438
Total operating expenses 22,935 24,289 46,970 49,416
OPERATING INCOME 4,442 3,801 8,039 4,636
Healthcare IT [Member] | Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Net revenue 24,077 24,580 48,719 47,301
Direct operating costs 11,763 12,710 24,666 25,254
Selling and marketing 1,110 1,657 2,234 3,417
General and administrative 2,343 2,021 4,455 4,602
Research and development 1,020 1,055 2,255 1,968
Depreciation and amortization 3,300 3,633 6,555 7,478
Restructuring costs 23 116 137 438
Total operating expenses 19,559 21,192 40,302 43,157
OPERATING INCOME 4,518 3,388 8,417 4,144
Medical Practice Management [Member] | Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Net revenue [1] 3,300 3,510 6,290 6,751
Direct operating costs 2,717 2,532 5,278 5,165
Selling and marketing 8 7 15 17
General and administrative 569 477 1,211 911
Research and development
Depreciation and amortization 82 81 164 166
Restructuring costs
Total operating expenses 3,376 3,097 6,668 6,259
OPERATING INCOME $ (76) $ 413 $ (378) $ 492
[1] This revenue represents fees based on our actual costs plus a percentage of the operating profit.